Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-02-21 @ 6:51 AM
Study NCT ID:
NCT00298233
Status:
COMPLETED
Last Update Posted:
2014-06-06
First Post:
2006-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
SEA 001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None